RxDoctor Payments Data

Gary Liao

Primary Podiatric Medicine · Durham, NCNPI 1275823569

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations.

$2,074in general payments, 2019–2025

Across 27 payments — averaging $76.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lifenet Health$332
  • Linvatec Corporation$251
  • Medtronic$250
  • Averitas Pharma Inc.$166
  • Forma Medical$143
  • In2bones USA, LLC$134
  • plus $797 from 16 others

What the payments were for

  • Speaking & faculty fees$201%
  • Food & beverage$2,05499%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,074 in reported general payments places this provider in the 60th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$62,497
Medicare patients
285
Services billed
785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate84$1,747
Gabapentin39$342
Meloxicam18$84
Cephalexin19$70

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →